Aurevix— Review, Pricing, Alternatives

Aurevix offers a Research Tier at $25 million annually and a Commercial Tier with options for $100 million annually or a $500 million perpetual license. Pricing reflects the value of early detection of advanced capability states and risk mitigation.

Aurevix does not offer a free tier. The available licensing options are the Research Tier and the Commercial Tier, both of which involve significant annual or perpetual fees.

Aurevix is currently validated for use with ChatGPT, Claude, Copilot, Perplexity, and Gemini. The AEON Protocol is theoretically applicable to any large language model with sufficient architectural complexity and observable behavioral output.

Existing AI safety frameworks focus on theoretical risks and preventing harmful behaviors, unlike Aurevix which is built from documented cross-platform observations of anomalous behaviors. Specific alternatives would depend on the user's particular needs for advanced capability state detection.

Aurevix licensing agreements include NDA terms that obligate licensees to implement reasonable security measures and limit access to need-to-know personnel. Specific GDPR compliance details would need to be confirmed directly with Aurevix.

The provided information does not specify whether Aurevix has a dedicated mobile version. The focus is on its application to LLMs and robotic data analysis, typically accessed via enterprise infrastructure.

An assessment with Aurevix can vary significantly. A preliminary assessment may take 2-4 hours, while a comprehensive assessment can span 20-40 hours across multiple sessions, potentially over 2-4 weeks.